A Co-designed Physical Activity Intervention in Fabry Disease
Co-design of a Physical Activity and Sedentary Behaviour Intervention for Adults with Fabry Disease
1 other identifier
observational
41
1 country
1
Brief Summary
Currently, treatments for Fabry disease are pharmacological and predominantly focus on the physical symptoms of the disease. In the general population and individuals with disabilities, increasing physical activity levels and reducing sedentary time can be an effective, non-pharmacological treatment to improve mental health and quality of life. Such interventions have not yet been developed or evaluated in people with Fabry disease. The aim of this study is to co-design a physical activity and sedentary behaviour intervention tailored to the needs of adults with Fabry disease. The study will seek to gain the expertise of adults with Fabry disease, specialist stakeholders (physicians, cardiologists and clinical nurse specialists) and lay specialist stakeholders (family and friends of adults with Fabry disease and members of staff and volunteers at the Society for Mucopolysaccharide Diseases). A range of views and experiences of physical activity and sedentary behaviour will be explored via focus groups (with individuals with Fabry disease and lay specialist stakeholders) and semi-structured interviews (with specialist stakeholders). The information gathered from the focus groups and interviews will then be utilised to inform participatory workshops (with individuals with Fabry disease) to test intervention concepts. Data from these activities will inform the design of a future intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFebruary 13, 2025
February 1, 2025
7 months
January 25, 2024
February 11, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Focus groups (adults with Fabry disease)
Themes describing adults with Fabry disease's views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of focus groups (using the Framework Method).
9 months
Focus groups (lay specialist stakeholders)
Themes describing lay specialist stakeholders' views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of focus groups (using the Framework Method).
9 months
Semi-structured interviews (specialist stakeholders)
Themes describing specialist stakeholders' views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of interviews (using the Framework Method).
9 months
Participatory workshops (adults with Fabry disease)
Themes describing adults with Fabry disease's views and experiences of initial intervention concepts- Emergence of themes describing participants' views and experiences from analysis of participatory workshops (using the Framework Method).
9 months
Study Arms (3)
Adults with Fabry disease
Focus groups and participatory workshops
Lay specialist stakeholders
Focus groups
Specialist stakeholders
Interviews
Interventions
Qualitative study (no intervention delivered)
Eligibility Criteria
Adults with Fabry disease, lay specialist stakeholders and specialist stakeholders who meet the eligibility criteria.
You may qualify if:
- Have been diagnosed with Fabry disease.
- Aged ≥ 18 years old.
- Able to independently ambulate with or without the use of a walking aid.
- Lives in the United Kingdom.
- Deemed eligible to participate following screening by a clinician (for participatory workshops).
- The circumstances in which an individual may be deemed ineligible to participate in the participatory workshops based on the clinician's assessment are as follows:
- Severe neuropathic pain.
- Stage 4 heart failure or other condition resulting in breathlessness to a level they cannot participate.
- Other clinical condition which dominates the clinical picture to the extent that it dominates the symptoms and biases the results.
You may not qualify if:
- Incapacity to provide written informed consent.
- Unable to communicate in English to a sufficient level to permit engagement in the study.
- Specialist stakeholders will be members of staff at NHS specialist centres for Fabry disease who are directly involved in the healthcare of adults with Fabry disease.
- Lay specialist stakeholders will be individuals who have been involved in supporting adults with Fabry disease, such as family, friends and members of staff at the Society for Mucopolysaccharide Diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brunel Universitylead
- Royal Free Hospital NHS Foundation Trustcollaborator
Study Sites (1)
Brunel University London
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer in Sport, Health and Exercise Sciences
Study Record Dates
First Submitted
January 25, 2024
First Posted
February 14, 2024
Study Start
March 1, 2024
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share